Nov 29, 2018
Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting
FRANKLIN LAKES, N.J.– BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems identify drug diversion at the 2018 American Society of Health-System Pharmacists (ASHP) Midyear Meeting.
Addiction to prescription narcotics in the United States has reached epidemic proportions, contributing to the opioid crisis and becoming a major driver of drug diversion within healthcare settings1,2,3. Diversion of drugs, for personal use or illegal distribution, can cause significant financial loss4 and potentially impact care to patients and staff safety5.
As part of the BD HealthSight™ platform that is designed to support enterprise-wide medication management, the new BD HealthSight™ diversion management application is the next step in the company’s efforts to address drug diversion through integrated solutions and analytics. The solution leverages data from existing BD products, including the BD Pyxis™ ES system, and the Electronic Medical Record (EMR) to provide actionable insights to assist with a hospital or health system’s diversion investigations.
“Medication diversion is a growing and complex challenge for hospitals and health systems. We believe that to best address this challenge, a holistic approach to medication management that includes a combination of connected technologies and robust analytics is required,” said Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD. “Specific cases of diversion can be difficult to detect, and the impact can be devastating from a patient and healthcare worker safety standpoint. The new BD HealthSight diversion management application is designed to address the unique challenges associated with diversion by tracking patterns and risky behavior to help identify diverters as early as possible.”
BD HealthSight™ diversion management is a hosted, cloud-based application that assists with drug diversion investigations by creating an investigation workflow to monitor, triage and assign potential diversion cases to specific investigators. Compared to traditional, statistically-based analytical tools that only look at amounts dispensed to identify potential diversion, BD utilizes machine learning algorithms and multiple dispensing behaviors —such as overrides, canceled transactions, delays in dispensing, administering and wasting medications — to surface clinicians whose behavior indicates higher risk for diversion. BD has partnered with Microsoft, who brings industry leading expertise in artificial intelligence (AI) and data science methodologies, to support development of these machine-learning based algorithms. Importantly, the application also aggregates EMR and dispensing cabinet data to automate a normally time-consuming and tedious manual review process to reconcile and automatically flag anomalous dispense, administration and waste transactions.
BD invites customers and media to join us at booth #320 at ASHP Midyear to learn more about the first in a series of solution developments from BD to address diversion management. To learn more about the new BD HealthSight™ diversion management analytics application, visit bd.com/diversion.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers,BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.
BD Public Relations
Monique N. Dolecki
BD Investor Relations
201. 847. 5378
|Jun 03, 2019||PrimeCare® Integrates MedTek21® to Offer Facility-based Genomic Testing|
|May 22, 2019||Letco Med Announces the Launch of a New Industry-Leading Website and E-Commerce ...|
|May 17, 2019||MEDISCA Granted Planetary Mixing Patent and Exclusive Distribution Agreement|
|May 02, 2019||Transaction Data Systems (TDS) Delivers Smarter Approach to Claim Reconciliation|
|Apr 22, 2019||Visante healthcare consulting firm announces Judi Jacobi, PharmD, to join consul...|
|Apr 17, 2019||As an aging population demands more efficient pharmacy solutions, the founder of...|
|Apr 17, 2019||Adam Wallace Named Chief Technology Officer at Transaction Data Systems (TDS)|
|Apr 15, 2019||PharmaLink to Exhibit at 2019 Asembia Specialty Pharmacy Summit|
|Apr 04, 2019||Transaction Data Systems (TDS) Announces Acquisition of Pharm Assess, Inc.|
|Apr 01, 2019||Chad Collins Named President of Akro-Mils and Jamco Products|
|Mar 22, 2019||Tutela Welcomes Octapharma Plasma|
|Mar 18, 2019||Verity Solutions Recognized as Category Leader for 340B Management Systems in 20...|
|Mar 07, 2019||Stormont Vail Health Partners with Omnicell to Enhance Medication Management Str...|
|Mar 06, 2019||Rebranding Focuses ALG Mission - Combining Our Best to Bring You Our Best|
|Mar 04, 2019||RXinsider Celebrates 20 Years, 1999 - 2019|
|Feb 28, 2019||Lupin launches Generic Ranolazine ER Tablets in U.S.|
|Feb 18, 2019||QS/1® Offers Compliance Packaging Label Solution|
|Feb 15, 2019||QS/1 Partnership Offers Compliant Patient Communications|
|Feb 14, 2019||RXinsider is Proud to Welcome our Newest Partners!|
|Feb 12, 2019||Albertsons Companies Pharmacies Adopt TemperPack's ClimaCell™ Packaging|
|Feb 07, 2019||Fagron Launches New Brand Identity and Purpose|
|Feb 07, 2019||Medicine-On-Time has come together with Clinical Support Services, a leader in M...|
|Feb 04, 2019||Letco Med and Ananda Professional Partner to Bring CBD and Education to Compound...|
|Jan 30, 2019||Texas Children’s Hospital Expands Partnership with Omnicell|
|Jan 16, 2019||Helmer Scientific Launches the First Professional Medical-grade Refrigerators|
|Jan 15, 2019||The Compliance Team™ celebrates 25 years of accreditation transformation|
|Jan 11, 2019||CORE Higher Education Group partners with Pharmacists Mutual|
|Jan 10, 2019||SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Pr...|
|Jan 08, 2019||Tutela Welcomes the Center for Organ Recovery and Education|
|Dec 13, 2018||PharmaLink Launches Updated Website|
Connect with thousands of pharmacy professionals throughout every practice setting.